Based on the provided data, Finland's antiinfective medicine market is set to grow from 2024 onwards, starting at 57.5 US Dollars PPP per capita in 2024 and reaching 62.8 in 2028. The year-on-year growth percentages are as follows: 2024 to 2025 (+2.3%), 2025 to 2026 (+2.4%), 2026 to 2027 (+2.2%), and 2027 to 2028 (+2.1%). This indicates a steady growth pattern in the market over the next five years.
Looking at the compounded annual growth rate (CAGR) for the period of 2024 to 2028, the average yearly growth is approximately 2.3%.
Future trends to watch for include:
- Potential increases in demand driven by aging population and increased prevalence of antibiotic-resistant infections.- Innovations in antiinfective drugs, including new formulations and delivery methods.- Government policies and healthcare system changes affecting accessibility and reimbursement.
Monitoring these trends will be crucial for stakeholders to adapt and capitalize on the evolving market conditions.
